179 related articles for article (PubMed ID: 18047935)
1. Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation.
Golocheikine AS; Saini D; Ramachandran S; Trulock EP; Patterson A; Mohanakumar T
Transpl Immunol; 2008 Jan; 18(3):260-3. PubMed ID: 18047935
[TBL] [Abstract][Full Text] [Related]
2. Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation.
Fields RC; Bharat A; Steward N; Aloush A; Meyers BF; Trulock EP; Chapman WC; Patterson GA; Mohanakumar T
Transplantation; 2006 Dec; 82(12):1596-601. PubMed ID: 17198242
[TBL] [Abstract][Full Text] [Related]
3. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation.
Bauwens AM; van de Graaf EA; van Ginkel WG; van Kessel DA; Otten HG
J Heart Lung Transplant; 2006 Apr; 25(4):416-9. PubMed ID: 16563971
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD30 measured after lung transplantation does not predict bronchiolitis obliterans syndrome in a tacrolimus/mycophenolate mofetil-based immunosuppressive regimen.
Kwakkel-van Erp JM; Otten HG; Paantjens AW; van Kessel DA; van Ginkel WG; van den Bosch JM; van de Graaf EA
J Heart Lung Transplant; 2008 Oct; 27(10):1172-5. PubMed ID: 18926413
[TBL] [Abstract][Full Text] [Related]
5. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
[TBL] [Abstract][Full Text] [Related]
6. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
[TBL] [Abstract][Full Text] [Related]
7. Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation.
White SR; Floreth T; Liao C; Bhorade SM
PLoS One; 2014; 9(7):e103643. PubMed ID: 25068264
[TBL] [Abstract][Full Text] [Related]
8. Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients' Survival.
Trailin AV; Ostapenko TI; Nykonenko TN; Nesterenko SN; Nykonenko OS
Dis Markers; 2017; 2017():9264904. PubMed ID: 28694560
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS).
Sato M; Ohmori-Matsuda K; Saito T; Matsuda Y; Hwang DM; Waddell TK; Singer LG; Keshavjee S
J Heart Lung Transplant; 2013 May; 32(5):484-91. PubMed ID: 23433813
[TBL] [Abstract][Full Text] [Related]
10. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.
Weigt SS; Wallace WD; Derhovanessian A; Saggar R; Saggar R; Lynch JP; Belperio JA
Semin Respir Crit Care Med; 2010 Apr; 31(2):189-207. PubMed ID: 20354932
[TBL] [Abstract][Full Text] [Related]
11. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
Jaramillo A; Fernández FG; Kuo EY; Trulock EP; Patterson GA; Mohanakumar T
Pediatr Transplant; 2005 Feb; 9(1):84-93. PubMed ID: 15667618
[TBL] [Abstract][Full Text] [Related]
12. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
[TBL] [Abstract][Full Text] [Related]
13. Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.
Verleden SE; Vos R; Vandermeulen E; Ruttens D; Bellon H; Heigl T; Van Raemdonck DE; Verleden GM; Lama V; Ross BD; Galbán CJ; Vanaudenaerde BM
Am J Transplant; 2016 Nov; 16(11):3262-3269. PubMed ID: 27367568
[TBL] [Abstract][Full Text] [Related]
14. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation.
Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB
Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723
[TBL] [Abstract][Full Text] [Related]
15. Blood CD9
Brosseau C; Danger R; Durand M; Durand E; Foureau A; Lacoste P; Tissot A; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Claustre J; Magnan A; Brouard S;
Am J Transplant; 2019 Nov; 19(11):3162-3175. PubMed ID: 31305014
[TBL] [Abstract][Full Text] [Related]
16. VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation.
Larsson-Callerfelt AK; Müller C; Andersson-Sjöland A; Thiman L; Larsson H; Hallgren O; Bjermer L; Eriksson L; Westergren-Thorsson G
Respir Med; 2020 May; 166():105944. PubMed ID: 32250877
[TBL] [Abstract][Full Text] [Related]
17. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage cell findings.
Reynaud-Gaubert M; Thomas P; Badier M; Cau P; Giudicelli R; Fuentes P
Am J Respir Crit Care Med; 2000 Jun; 161(6):1924-9. PubMed ID: 10852768
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation.
Budding K; van de Graaf EA; Kardol-Hoefnagel T; Kwakkel-van Erp JM; Luijk BD; Oudijk ED; van Kessel DA; Grutters JC; Hack CE; Otten HG
Sci Rep; 2016 May; 6():26274. PubMed ID: 27215188
[TBL] [Abstract][Full Text] [Related]
19. Bronchiolitis obliterans syndrome development in lung transplantation patients.
Parada MT; Alba A; Sepúlveda C
Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
[TBL] [Abstract][Full Text] [Related]
20. Acute rejection and humoral sensitization in lung transplant recipients.
Martinu T; Chen DF; Palmer SM
Proc Am Thorac Soc; 2009 Jan; 6(1):54-65. PubMed ID: 19131531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
